Trending Now
Brickell Biotech Inc. (NASDAQ: BBI) Announces Q3 2021 Financial Results and...
Brickell Biotech Inc. (NASDAQ: BBI) has announced Q3 2021 financial results and also offered a corporate update about its development programs.
Positive topline results were...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) Reports $19.5 Million from Sales of Common...
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) has been very active in the development of novel therapies, which will improve the lives of people suffering from immune-mediated...
MAKE IT MODERN
LATEST REVIEWS
Otonomy Inc (NASDAQ: OTIC) Issues an Update on Its OTO-413 Clinical...
Otonomy Inc (NASDAQ: OTIC) recently updated its shareholders and third parties about the status of its latest product OTO -413 clinical trials. The company...
MAKE IT MODERN
PERFORMANCE TRAINING
Adverum Biotechnologies Inc. (NASDAQ:ADVM) Announces Q3 2020 Results With FDA removing Partial Hold On...
Adverum Biotechnologies Inc. (NASDAQ:ADVM) has announced recent corporate updates and financial results for Q3 2020.
Adverum advancing DME and wet AMD programs
Laurent Fischer, the...
Sorrento Therapeutics Inc. (NASDAQ:SRNE) Secures License For Novel Antibody-Drug-Nanoparticle Albumin-Bound Immune Complex Tech
Sorrento Therapeutics Inc. (NASDAQ:SRNE) has signed an exclusive license agreement with Mayo Clinic for a breakthrough tech platform. The technology can generate enhanced diversity...
Celsion Corporation (NASDAQ:CLSN) Unveils An Update On Its Phase I/II OVATION 2 Study
Celsion Corporation (NASDAQ:CLSN) has been focusing on its Phase I/II OVATION 2 Study that involved GEN-1 in patients struggling with advanced ovarian cancer. The...
Flora Growth Corp (NASDAQ:FLGC) intends to explore a preventative application against COVID-19
Recently, Flora Growth Corp. (NASDAQ:FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced...
Top Opportunities in the Dirt Cheap Apparel Space (LULU, FBCD, TJX, SFIX, AEO, GPS,...
Fashion brands and apparel retailers represent an interesting focus for investors pining for value in cash-rich portfolios after a brutal first half of the...
MAKE IT MODERN
